Ask NYC Browse All Data Public Safety Transportation Health Buildings

New York City Community Health Survey

The New York City Community Health Survey (CHS) is a telephone survey conducted annually by the DOHMH, Division of Epidemiology, Bureau of Epidemiology Services. CHS provides robust data on the health of New Yorkers, including neighborhood, borough, and citywide estimates on a broad range of chronic diseases and behavioral risk factors. The data are analyzed and disseminated to influence health program decisions, and increase the understanding of the relationship between health behavior and health status.

For more information see EpiQuery, https://a816-health.nyc.gov/hdi/epiquery/visualizations?PageType=ps&PopulationSource=CHS

Health Department of Health and Mental Hygiene Dataset csut-3wpr 12 fields
DOWNLOAD CSV
Dataset fields
Showing 33 real records
Prevalence 2020
Prevelance: Prevalence 2020 • Year: 2020 • Q 1: 12.6
Prevelance
Prevalence 2020
Year
2020
Q 1
12.6
Q 2
12.4
Q 3
28.8
Q 4
22.3
Q 5
10.9
Q 6
16.6
Q 7
25.4
Q 8
71.8
Q 9
80.8
Q 10
69.8
Lower 95% CI 2020
Prevelance: Lower 95% CI 2020 • Year: 2020 • Q 1: 11.6
Prevelance
Lower 95% CI 2020
Year
2020
Q 1
11.6
Q 2
11.4
Q 3
27.5
Q 4
21.0
Q 5
10.0
Q 6
15.5
Q 7
24.0
Q 8
69.5
Q 9
79.6
Q 10
66.1
Upper 95% CI 2020
Prevelance: Upper 95% CI 2020 • Year: 2020 • Q 1: 13.7
Prevelance
Upper 95% CI 2020
Year
2020
Q 1
13.7
Q 2
13.6
Q 3
30.3
Q 4
23.7
Q 5
12.0
Q 6
17.8
Q 7
26.8
Q 8
74.0
Q 9
82.0
Q 10
73.2
Prevalence 2019
Prevelance: Prevalence 2019 • Year: 2019 • Q 1: 12.7
Prevelance
Prevalence 2019
Year
2019
Q 1
12.7
Q 2
12.4
Q 3
16.2
Q 4
22.1
Q 5
11.9
Q 6
18.9
Q 7
24.8
Q 8
70.7
Q 9
76.6
Q 10
67.6
Lower 95% CI 2019
Prevelance: Lower 95% CI 2019 • Year: 2019 • Q 1: 11.6
Prevelance
Lower 95% CI 2019
Year
2019
Q 1
11.6
Q 2
11.3
Q 3
15.0
Q 4
20.8
Q 5
10.8
Q 6
17.6
Q 7
23.4
Q 8
68.4
Q 9
75.2
Q 10
64.2
Upper 95% CI 2019
Prevelance: Upper 95% CI 2019 • Year: 2019 • Q 1: 14.0
Prevelance
Upper 95% CI 2019
Year
2019
Q 1
14.0
Q 2
13.5
Q 3
17.5
Q 4
23.5
Q 5
13.0
Q 6
20.2
Q 7
26.2
Q 8
72.9
Q 9
77.9
Q 10
70.7
Prevalence 2018
Prevelance: Prevalence 2018 • Year: 2018 • Q 1: 11.6
Prevelance
Prevalence 2018
Year
2018
Q 1
11.6
Q 2
11.1
Q 3
15.6
Q 4
23.6
Q 5
12.8
Q 6
17.8
Q 7
25.7
Q 8
69.1
Q 9
76.8
Q 10
62.8
Lower 95% CI 2018
Prevelance: Lower 95% CI 2018 • Year: 2018 • Q 1: 10.6
Prevelance
Lower 95% CI 2018
Year
2018
Q 1
10.6
Q 2
10.2
Q 3
14.6
Q 4
22.4
Q 5
11.8
Q 6
16.7
Q 7
24.5
Q 8
67.0
Q 9
75.6
Q 10
59.7
Upper 95% CI 2018
Prevelance: Upper 95% CI 2018 • Year: 2018 • Q 1: 12.6
Prevelance
Upper 95% CI 2018
Year
2018
Q 1
12.6
Q 2
12.1
Q 3
16.8
Q 4
25.0
Q 5
13.8
Q 6
19.0
Q 7
27.1
Q 8
71.1
Q 9
77.9
Q 10
65.8
Prevalence 2017
Prevelance: Prevalence 2017 • Year: 2017 • Q 1: 11.8
Prevelance
Prevalence 2017
Year
2017
Q 1
11.8
Q 2
10.3
Q 3
15.2
Q 4
23.0
Q 5
13.4
Q 6
17.3
Q 7
25.1
Q 8
69.9
Q 9
76.8
Q 10
66.1
Lower 95% CI 2017
Prevelance: Lower 95% CI 2017 • Year: 2017 • Q 1: 10.9
Prevelance
Lower 95% CI 2017
Year
2017
Q 1
10.9
Q 2
9.5
Q 3
14.2
Q 4
21.8
Q 5
12.5
Q 6
16.2
Q 7
23.9
Q 8
68.0
Q 9
75.7
Q 10
63.4
Upper 95% CI 2017
Prevelance: Upper 95% CI 2017 • Year: 2017 • Q 1: 12.8
Prevelance
Upper 95% CI 2017
Year
2017
Q 1
12.8
Q 2
11.2
Q 3
16.3
Q 4
24.2
Q 5
14.4
Q 6
18.4
Q 7
26.3
Q 8
71.6
Q 9
77.9
Q 10
68.8
Prevalence 2016
Prevelance: Prevalence 2016 • Year: 2016 • Q 1: 10.9
Prevelance
Prevalence 2016
Year
2016
Q 1
10.9
Q 2
10.5
Q 3
16.8
Q 4
22.7
Q 5
13.1
Q 6
17.0
Q 7
23.6
Q 8
68.5
Q 9
78.0
Q 10
65.4
Lower 95% CI 2016
Prevelance: Lower 95% CI 2016 • Year: 2016 • Q 1: 10.0
Prevelance
Lower 95% CI 2016
Year
2016
Q 1
10.0
Q 2
9.7
Q 3
15.7
Q 4
21.5
Q 5
12.2
Q 6
15.9
Q 7
22.5
Q 8
66.5
Q 9
76.8
Q 10
62.4
Upper 95% CI 2016
Prevelance: Upper 95% CI 2016 • Year: 2016 • Q 1: 11.8
Prevelance
Upper 95% CI 2016
Year
2016
Q 1
11.8
Q 2
11.5
Q 3
17.9
Q 4
23.9
Q 5
14.1
Q 6
18.1
Q 7
24.9
Q 8
70.4
Q 9
79.1
Q 10
68.3
Prevalence 2015
Prevelance: Prevalence 2015 • Year: 2015 • Q 1: 12.6
Prevelance
Prevalence 2015
Year
2015
Q 1
12.6
Q 2
9.9
Q 3
16.3
Q 4
23.7
Q 5
14.3
Q 6
17.2
Q 7
24.1
Q 8
69.9
Q 9
77.4
Q 10
65.5
Lower 95% CI 2015
Prevelance: Lower 95% CI 2015 • Year: 2015 • Q 1: 11.7
Prevelance
Lower 95% CI 2015
Year
2015
Q 1
11.7
Q 2
9.1
Q 3
15.2
Q 4
22.5
Q 5
13.3
Q 6
16.1
Q 7
23.0
Q 8
68.1
Q 9
76.3
Q 10
62.7
Upper 95% CI 2015
Prevelance: Upper 95% CI 2015 • Year: 2015 • Q 1: 13.6
Prevelance
Upper 95% CI 2015
Year
2015
Q 1
13.6
Q 2
10.8
Q 3
17.4
Q 4
24.9
Q 5
15.3
Q 6
18.3
Q 7
25.3
Q 8
71.6
Q 9
78.4
Q 10
68.1
Prevalence 2014
Prevelance: Prevalence 2014 • Year: 2014 • Q 1: 13.8
Prevelance
Prevalence 2014
Year
2014
Q 1
13.8
Q 2
9.6
Q 3
15.6
Q 4
22.5
Q 5
13.9
Q 6
16.5
Q 7
24.7
Q 8
69.9
Q 9
77.8
Q 10
64.2
Lower 95% CI 2014
Prevelance: Lower 95% CI 2014 • Year: 2014 • Q 1: 12.8
Prevelance
Lower 95% CI 2014
Year
2014
Q 1
12.8
Q 2
8.7
Q 3
14.5
Q 4
21.2
Q 5
12.8
Q 6
15.4
Q 7
23.4
Q 8
67.8
Q 9
76.6
Q 10
60.7
Upper 95% CI 2014
Prevelance: Upper 95% CI 2014 • Year: 2014 • Q 1: 14.8
Prevelance
Upper 95% CI 2014
Year
2014
Q 1
14.8
Q 2
10.5
Q 3
16.7
Q 4
23.8
Q 5
14.9
Q 6
17.7
Q 7
26.0
Q 8
72.0
Q 9
78.9
Q 10
67.6
Prevalence 2013
Prevelance: Prevalence 2013 • Year: 2013 • Q 1: 20.9
Prevelance
Prevalence 2013
Year
2013
Q 1
20.9
Q 2
11.2
Q 3
19.1
Q 4
23.3
Q 5
16.1
Q 6
18.2
Q 7
23.4
Q 8
69.0
Q 9
76.9
Q 10
66.8
Lower 95% CI 2013
Prevelance: Lower 95% CI 2013 • Year: 2013 • Q 1: 19.7
Prevelance
Lower 95% CI 2013
Year
2013
Q 1
19.7
Q 2
10.3
Q 3
18.0
Q 4
22.1
Q 5
15.0
Q 6
17.0
Q 7
22.2
Q 8
67.0
Q 9
75.7
Q 10
63.7
Upper 95% CI 2013
Prevelance: Upper 95% CI 2013 • Year: 2013 • Q 1: 22.2
Prevelance
Upper 95% CI 2013
Year
2013
Q 1
22.2
Q 2
12.2
Q 3
20.3
Q 4
24.6
Q 5
17.2
Q 6
19.4
Q 7
24.7
Q 8
71.0
Q 9
78.0
Q 10
69.8
Prevalence 2012
Prevelance: Prevalence 2012 • Year: 2012 • Q 1: 19.8
Prevelance
Prevalence 2012
Year
2012
Q 1
19.8
Q 2
11.1
Q 3
18.3
Q 4
28.2
Q 5
15.5
Q 6
19.6
Q 7
24.2
Q 8
68.5
Q 9
78.7
Q 10
61.8
Lower 95% CI 2012
Prevelance: Lower 95% CI 2012 • Year: 2012 • Q 1: 18.5
Prevelance
Lower 95% CI 2012
Year
2012
Q 1
18.5
Q 2
10.1
Q 3
17.0
Q 4
26.7
Q 5
14.4
Q 6
18.2
Q 7
22.8
Q 8
66.3
Q 9
77.5
Q 10
58.5
Upper 95% CI 2012
Prevelance: Upper 95% CI 2012 • Year: 2012 • Q 1: 21.3
Prevelance
Upper 95% CI 2012
Year
2012
Q 1
21.3
Q 2
12.2
Q 3
19.7
Q 4
29.6
Q 5
16.8
Q 6
20.9
Q 7
25.5
Q 8
70.5
Q 9
79.9
Q 10
64.9
Prevalence 2011
Prevelance: Prevalence 2011 • Year: 2011 • Q 1: 18.6
Prevelance
Prevalence 2011
Year
2011
Q 1
18.6
Q 2
10.7
Q 3
16.9
Q 4
29.9
Q 5
14.8
Q 6
17.9
Q 7
23.7
Q 8
68.6
Q 9
78.2
Q 10
67.4
Lower 95% CI 2011
Prevelance: Lower 95% CI 2011 • Year: 2011 • Q 1: 17.0
Prevelance
Lower 95% CI 2011
Year
2011
Q 1
17.0
Q 2
9.6
Q 3
15.5
Q 4
28.2
Q 5
13.5
Q 6
16.4
Q 7
22.2
Q 8
66.2
Q 9
76.7
Q 10
63.9
Upper 95% CI 2011
Prevelance: Upper 95% CI 2011 • Year: 2011 • Q 1: 20.3
Prevelance
Upper 95% CI 2011
Year
2011
Q 1
20.3
Q 2
12.0
Q 3
18.5
Q 4
31.7
Q 5
16.3
Q 6
19.6
Q 7
25.3
Q 8
70.8
Q 9
79.6
Q 10
70.7
Prevalence 2010
Prevelance: Prevalence 2010 • Year: 2010 • Q 1: 16.7
Prevelance
Prevalence 2010
Year
2010
Q 1
16.7
Q 2
10.3
Q 4
30.3
Q 5
14.0
Q 7
23.4
Q 8
67.5
Q 9
79.1
Q 10
62.3
Lower 95% CI 2010
Prevelance: Lower 95% CI 2010 • Year: 2010 • Q 1: 15.4
Prevelance
Lower 95% CI 2010
Year
2010
Q 1
15.4
Q 2
9.4
Q 4
28.8
Q 5
12.9
Q 7
22.1
Q 8
65.4
Q 9
77.8
Q 10
59.4
Upper 95% CI 2010
Prevelance: Upper 95% CI 2010 • Year: 2010 • Q 1: 18.0
Prevelance
Upper 95% CI 2010
Year
2010
Q 1
18.0
Q 2
11.4
Q 4
31.8
Q 5
15.3
Q 7
24.8
Q 8
69.4
Q 9
80.3
Q 10
65.1
NYC Data AI • Public-data exploration interface